NCT07203222 Comparison of Effectiveness of Low Dose Laser and Transcutaneous Electrical Stimulation in Hemiplegic Shoulder
| NCT ID | NCT07203222 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara Etlik City Hospital |
| Condition | Hemiplegic Shoulder Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2025-09-24 |
| Primary Completion | 2026-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 45 participants in total. It began in 2025-09-24 with a primary completion date of 2026-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim of this study is to compare the efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) and Low Level Laser Therapy (LLLT), which are analgesic modalities that play an important role in the treatment of this frequently encountered complication. The secondary aim of the study is to evaluate its effectiveness on upper extremity function, quality of life, sleep, and fatigue.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18-75 years * Patients with shoulder pain on the hemiplegic side \*Mini mental state examination ≥ 25 * History of stroke within the last 2 weeks to 6 months * Patients with shoulder pain scoring 40-100 points on the visual analogue scale (moderate to severe) will be included. Exclusion Criteria: * Patients who refuse to provide written consent or attend follow-up visits * Being under 18 years of age * Patients with motor aphasia * Patients who have had a shoulder injection within the last 3 months * Patients who have undergone upper extremity botulinum toxin application within the last 6 months \*Pregnant women or those planning to become pregnant * Inflammatory rheumatic disease * Patients who have undergone shoulder injury and surgery prior to stroke * Patients with other conditions that could explain shoulder pain * Patients with complex regional pain syndrome * Patients with a history of epilepsy, pacemaker, or arrhythmia diagnosis * Malignancy * Diseases such as Alzheimer's or dementia that cause cognitive impairment -History of psychiatric disorders such as major depression or personality disorders * Alcohol and drug addiction
Contact & Investigator
nihal tezel, associate professor
STUDY DIRECTOR
Ankara Etlik City Hospital
Frequently Asked Questions
Who can join the NCT07203222 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Hemiplegic Shoulder Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07203222 currently recruiting?
Yes, NCT07203222 is actively recruiting participants. Contact the research team at aliyeaygunn@hotmail.com for enrollment information.
Where is the NCT07203222 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07203222 clinical trial?
NCT07203222 is sponsored by Ankara Etlik City Hospital. The principal investigator is nihal tezel, associate professor at Ankara Etlik City Hospital. The trial plans to enroll 45 participants.